AMPLEFORTH SURGERY
BACK LANE, AMPLEFORTH, YORK
CKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 57 | 69 | 82.6% | |
| CKD 4 | 2008 | 55 | 66 | 83.3% | |
| CKD 5 | 2009 | 3 | 3 | 100.0% | |
| CKD 5 | 2010 | 2 | 2 | 100.0% | |
| CKD 5 | 2011 | 2 | 2 | 100.0% | |
| CKD 5 | 2012 | 2 | 2 | 100.0% | |
| CKD 5 | 2013 | 2 | 2 | 100.0% | |
| CKD003 | 2014 | 7 | 8 | 87.5% | |
| CKD003 | 2015 | 14 | 16 | 87.5% | |
| NM84 | 2016 | 15 | 17 | 88.2% | |
| NM84 | 2017 | 14 | 18 | 77.8% | |
| NM84 | 2019 | 7 | 11 | 63.6% | |
| NM84 | 2020 | 7 | 9 | 77.8% | |
| NM84 | 2022 | 7 | 13 | 53.8% | |
| NM84 | 2023 | 9 | 14 | 64.3% |
